Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net Sales	$ 11,446,048	$ 5,875,611	$ 32,944,217	$ 15,139,347
Cost of Goods Sold	8,790,764	5,036,997	25,956,853	11,847,842
Gross Profit	2,655,284	838,614	6,987,364	3,291,505
Operating Expenses
Research and development	91,085	93,522	460,588	234,885
Selling General and Administrative Expenses	5,013,988	3,505,097	15,200,486	10,637,538
Loss on impairment of goodwill and intangibles	0	0	0	1,138,203
Total Operating Expenses	5,105,073	3,598,619	15,661,074	12,010,626
Operating Loss	(2,449,789)	(2,760,005)	(8,673,710)	(8,719,121)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	1,206	34,804	2,124	46,521
Interest expense	(558,268)	(43,037)	(1,434,329)	(96,113)
Gain (Loss) on change in Fair Market Value of Contingent Consideration	434,000	0	1	(240,000)
Gain on Settlement of Contingent Consideration (Note 2)	0	0	0	1,700,000
Other Income	0	67,765	0	69,713
Total Other Income (Expense)	(123,062)	59,532	(1,432,204)	1,480,121
Loss Before Provision for Income Taxes	(2,572,851)	(2,700,473)	(10,105,914)	(7,239,000)
Benefit from Income Taxes	0	0	0	0
Net Loss	(2,572,851)	(2,700,473)	(10,105,914)	(7,239,000)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(424,750)	(362,250)	(1,194,231)	(1,086,750)
Net Loss attributable to common stockholders	$ (2,997,601)	$ (3,062,723)	$ (11,300,145)	$ (8,325,750)